Cargando…

Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector

Human prostate tumor vaccine and gene therapy trials using ex vivo methods to prime dendritic cells (DCs) with prostate specific membrane antigen (PSMA) have been somewhat successful, but to date the lengthy ex vivo manipulation of DCs has limited the widespread clinical utility of this approach. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Briana Jill, Bhatia, Shilpa, Adams, Lisa K., Boling, Susan, Carroll, Jennifer L., Li, Xiao-Lin, Rogers, Donna L., Korokhov, Nikolay, Kovesdi, Imre, Pereboev, Alexander V., Curiel, David T., Mathis, J. Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466199/ https://www.ncbi.nlm.nih.gov/pubmed/23056548 http://dx.doi.org/10.1371/journal.pone.0046981

Ejemplares similares

Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells
por: Huang, D, et al.
Publicado: (2007)

Genetic Incorporation of Human Metallothionein into the Adenovirus Protein IX for Non-Invasive SPECT Imaging
por: Mathis, J. Michael, et al.
Publicado: (2011)

CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
por: Bhatia, Shilpa, et al.
Publicado: (2016)

Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma
por: Jessup, J. Milburn, et al.
Publicado: (2019)

Development of an adenovirus vector vaccine platform for targeting dendritic cells
por: Sharma, Piyush K, et al.
Publicado: (2017)

Efficient Gene Transduction by RGB‐fiber Modified Recombinant Adenovirus into Dendritic Cells
por: Asada‐Mikami, Rumiko, et al.
Publicado: (2001)

Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2015)

Effects of mutating α-tubulin lysine 40 on sensory dendrite development
por: Jenkins, Brian V., et al.
Publicado: (2017)

Adenoviral Producer Cells
por: Kovesdi, Imre, et al.
Publicado: (2010)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Derivation of a Triple Mosaic Adenovirus for Cancer Gene Therapy
por: Tang, Yizhe, et al.
Publicado: (2009)

Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
por: Bakacs, Tibor, et al.
Publicado: (2018)

An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
por: Bakacs, Tibor, et al.
Publicado: (2022)

Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
por: Bakacs, Tibor, et al.
Publicado: (2023)

Comparative analysis of the impact of 40 adenovirus types on dendritic cell activation and CD8(+) T cell proliferation capacity for the identification of favorable immunization vector candidates
por: Wang, Xiaoyan, et al.
Publicado: (2023)

VARIATION IN THE ONCOGENIC POTENTIAL OF HUMAN ADENOVIRUSES CARRYING A DEFECTIVE SV40 GENOME (PARA)
por: Rapp, Fred, et al.
Publicado: (1968)

Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections
por: Bakacs, Tibor, et al.
Publicado: (2022)

CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen
por: Flatt, Justin W., et al.
Publicado: (2012)

STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : II. DEFECTIVENESS OF THE HYBRID PARTICLES
por: Rowe, Wallace P., et al.
Publicado: (1965)

Rotavirus y adenovirus 40–41 como causantes de gastroenteritis infantil
por: Ciruela, P., et al.
Publicado: (2004)

Multiparametric dynamic whole-body PSMA PET/CT using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007
por: Dias, André H., et al.
Publicado: (2023)

Evaluation of adenovirus capsid labeling versus transgene expression
por: Li, Jing, et al.
Publicado: (2010)

Analysis of purified Wild type and mutant adenovirus particles by SILAC based quantitative proteomics
por: Alqahtani, Ali, et al.
Publicado: (2014)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

A Strategy for Adenovirus Vector Targeting with a Secreted Single Chain Antibody
por: Glasgow, Joel N., et al.
Publicado: (2009)

Efficient Amplification of Chimeric Adenovirus 5/40S Vectors Carrying the Short Fiber Protein of Ad40 in Suspension Cell Cultures
por: Miralles, Marta, et al.
Publicado: (2012)

Derivation of a Myeloid Cell-Binding Adenovirus for Gene Therapy of Inflammation
por: Alberti, Michael O., et al.
Publicado: (2012)

Identification of FAM111A as an SV40 Host Range Restriction and Adenovirus Helper Factor
por: Fine, Debrah A., et al.
Publicado: (2012)

Dendritic cells transduced with TIPE-2 recombinant adenovirus induces T cells suppression
por: Liu, Shudong, et al.
Publicado: (2021)

Immortalisation of human oesophageal epithelial cells by a recombinant SV40 adenovirus vector.
por: Inokuchi, S., et al.
Publicado: (1995)

PSMA Theranostics: Science and Practice
por: Mokoala, Kgomotso, et al.
Publicado: (2021)

(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2017)

Role of CD40 ligation in dendritic cell semimaturation
por: Gerlach, Anna-Maria, et al.
Publicado: (2012)

PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
por: Bychkov, Andrey, et al.
Publicado: (2017)

Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer
por: Nelson, Amy R, et al.
Publicado: (2009)

Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors
por: Bontkes, Hetty J., et al.
Publicado: (2005)

Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021)

Advances in PSMA theranostics
por: Jeitner, Thomas M., et al.
Publicado: (2022)

The Change of Immunoactivity of Dendritic Cells Induced by Mouse 4-1BBL Recombinant Adenovirus
por: Youlin, Kuang, et al.
Publicado: (2010)

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma
por: Naveh, Hadas Prag, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j5hrjn7phvpsvhm3c8r1iht06g